Form 4: Cadre Holdings Director, Deborah A. DeCotis, Reports Stock Option Grant

Deborah A. DeCotis, a director of Cadre Holdings, Inc., reported the acquisition of 16,000 stock options on March 18, 2024.

Summary

• On March 18, 2024, Deborah A. DeCotis, a director of Cadre Holdings, Inc., was granted 16,000 stock options.
• The options have an exercise price of $34.66.
• The options were granted under the Issuer's 2021 Stock Incentive Plan.
• The options vest in four equal quarterly tranches starting March 31, 2024, and ending December 31, 2024.
• The options expire on March 18, 2034.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants, which is generally neutral. The grant itself can be seen as a positive sign of aligning director interests with shareholders, but it's not a major event.

Positives

• The grant of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service and contribution to the company's success.

Industry Context

Stock option grants are a common form of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors in publicly traded companies.
• The vesting schedule of quarterly tranches is a fairly typical approach to incentivize long-term commitment.
• The specific number of options granted and the exercise price would need to be compared to similar companies in the industry to assess its relative value.

Stakeholder Impact

• The stock option grant could potentially incentivize the director to make decisions that increase shareholder value.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates